Fasching PA, Slamon D, Nowecki Z, Kukielka-Budny B, et al. Health-related quality of life in patients with HR+/HER2- early breast cancer treated with ribociclib plus a nonsteroidal aromatase inhibitor: results from the NATALEE trial. Clin Cancer Res 2025 Feb 28. doi: 10.1158/1078-0432.CCR-24-1724.
PMID: 40019493